Retaglutide is a novel GLP-1 receptor agonist currently under study for the treatment of type 2 diabetes. This drug works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone that https://mattiehdoz104517.mdkblog.com/45046057/trelaglutide-exploring-a-new-therapy-for-chronic-diseases